Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial
<p>Abstract</p> <p>Background</p> <p>Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS). This double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or in t...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-10-01
|
| Series: | Respiratory Research |
| Subjects: | |
| Online Access: | http://respiratory-research.com/content/12/1/132 |